Full Text Available
Note: Clicking the button above will open the full text document at the original institutional repository in a new window.
| Published in: | Radiology and Oncology |
|---|---|
| Format: | Online Article RSS Article |
| Published: |
2026
|
| Subjects: | |
| Tags: |
No Tags, Be the first to tag this record!
|
| _version_ | 1868552801415593984 |
|---|---|
| collection | WordPress RSS FRELIP Feed Integration |
| container_title | Radiology and Oncology |
| description | |
| discipline_display | Oncology |
| discipline_facet | Oncology |
| format | Online Article RSS Article |
| genre | Journal Article |
| id | rss_article:61372 |
| institution | FRELIP |
| journal_source_facet | Radiology and Oncology |
| last_indexed | 2026-06-20T21:26:42.861Z |
| publishDate | 2026 |
| publishDateSort | 2026 |
| record_format | rss_article |
| spellingShingle | Conversion therapy for advanced hepatocellular carcinoma following complete response to transarterial radioembolization combined with atezolizumab and bevacizumab Oncology General Oncology |
| sub_discipline_display | General |
| sub_discipline_facet | General |
| subject_display | Oncology General Oncology |
| subject_facet | Oncology General Oncology |
| title | Conversion therapy for advanced hepatocellular carcinoma following complete response to transarterial radioembolization combined with atezolizumab and bevacizumab |
| title_alt | Terapia de conversión para el carcinoma hepatocelular avanzado después de respuesta completa a radioembolización transarterial combinada con atezolizumab y bevacizumab Thérapie de conversion pour le carcinome hépatocellulaire avancé après réponse complète à la radioembolisation transartérielle combinée à l'atézolizumab et au bévacizumab Terapia de conversão para carcinoma hepatocelular avançado após resposta completa à radioembolização transarterial combinada com atezolizumabe e bevacizumabe |
| title_auth | Conversion therapy for advanced hepatocellular carcinoma following complete response to transarterial radioembolization combined with atezolizumab and bevacizumab |
| title_es_txt | Terapia de conversión para el carcinoma hepatocelular avanzado después de respuesta completa a radioembolización transarterial combinada con atezolizumab y bevacizumab |
| title_fr_txt | Thérapie de conversion pour le carcinome hépatocellulaire avancé après réponse complète à la radioembolisation transartérielle combinée à l'atézolizumab et au bévacizumab |
| title_full | Conversion therapy for advanced hepatocellular carcinoma following complete response to transarterial radioembolization combined with atezolizumab and bevacizumab |
| title_fullStr | Conversion therapy for advanced hepatocellular carcinoma following complete response to transarterial radioembolization combined with atezolizumab and bevacizumab |
| title_full_unstemmed | Conversion therapy for advanced hepatocellular carcinoma following complete response to transarterial radioembolization combined with atezolizumab and bevacizumab |
| title_pt_txt | Terapia de conversão para carcinoma hepatocelular avançado após resposta completa à radioembolização transarterial combinada com atezolizumabe e bevacizumabe |
| title_short | Conversion therapy for advanced hepatocellular carcinoma following complete response to transarterial radioembolization combined with atezolizumab and bevacizumab |
| title_sort | conversion therapy for advanced hepatocellular carcinoma following complete response to transarterial radioembolization combined with atezolizumab and bevacizumab |
| topic | Oncology General Oncology |
| url | https://sciendo.com/article/10.2478/raon-2026-0015 |